Sort
39,280 grants matching “leukemia”
Minority Based Community Clinical Oncology Program
$692,570David J Peace · University Of Illinois At Chicago · U10 · FY2010 · CA
Molecular Phenotypes for Lung Diseases
$692,485David Brian Corry · Baylor College Of Medicine · R01 · FY2009 · HL
Clinical Development of Novel Drugs for Children with Refractory Cancers
$692,483Brigitte Widemann · Division Of Clinical Sciences - Nci · ZIA · FY2014 · CA
Statins & Lymphoid Malignancy Risk in a Large Multi-Site Population-Based Cohort
$692,432Christine C Johnson · Henry Ford Health System · R01 · FY2010 · CA
Teens at Risk: Prenatal Cocaine and Postnatal Challenges
$692,235Virginia Delaney-Black · Wayne State University · R01 · FY2010 · DA
Molecular Phenotypes for Lung Diseases
$692,215David Brian Corry · Baylor College Of Medicine · R01 · FY2010 · HL
Project 2: : Systematic discovery of cell-extrinsic mechanisms of cancer drug resistance
$692,202Alex K Shalek · Massachusetts Institute Of Technology · U54 · FY2020 · CA
Personalized Adoptive T-cell Therapy for AML
$692,077David E Avigan · Beth Israel Deaconess Medical Center · R01 · FY2024 · CA
KSHV Latency Regulation
$691,972Kenneth M Kaye · Brigham And Women'S Hospital · R01 · FY2023 · AI
KSHV Latency Regulation
$691,972Kenneth M Kaye · Brigham And Women'S Hospital · R01 · FY2024 · AI
Functional and Mechanistic Study of Histone Crotonylation in Hematological Malignancies
$691,925Charles David Allis · Rockefeller University · R01 · FY2020 · CA
Development of small molecule inhibitor of Mcl-1 for cancer treatment
$691,769Michael H Cardone · Eutropics Pharmaceuticals, Inc. · R44 · FY2010 · CA
Improving Informed Consent in Childhood Cancer Trials
$691,717Eric D. Kodish · Cleveland Clinic Lerner Com-Cwru · R01 · FY2006 · CA
Predicting Clinical Outcome After Traditional and Ibrutinib-based Therapy In Chronic Lymphocytic Leukemia
$691,685Neil E Kay · Mayo Clinic Rochester · R01 · FY2018 · CA
ITSC for Leukemia: Novel Molecular Strategies for NCTN: "Individualized" Therapie
$691,472Clara D Bloomfield · Ohio State University · U10 · FY2015 · CA
Monitoring disease progression in follicular lymphoma with next-gen sequencing
$691,364Christopher S Carlson · Fred Hutchinson Cancer Research Center · R01 · FY2016 · CA
Immunology and Pathology of Chronic Murine Leukemia Virus Infections
$691,232Kim Hasenkrug · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Immunology And Pathology Of Acute Murine Leukemia Virus Infections
$691,232Kim Hasenkrug · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Immune Reconstitution
$691,117Daniel Cesar Douek · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Achieving Xenograft Tolerance through Thymic Programming in Primates
$690,993Greg Nowak · Columbia University Health Sciences · P01 · FY2024 · AI
Molecular pathogenesis and therapy innovation for Merkel cell carcinoma
$690,982Isaac Brownell · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Clinical Trials with Immunotoxins
$690,977Ira Pastan · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Psychosocial Risk in Young Survivors of Early Onset Pediatric Cancer: The Role of Physical and Neurocognitive Late Effects
$690,907Cynthia A Gerhardt · Research Inst Nationwide Children'S Hosp · R01 · FY2025 · CA
Combinatorial application of nanoscale technologies to target a novel mechanism of immune evasion by cancer cells
$690,825Shiladitya Sengupta · Brigham And Women'S Hospital · R01 · FY2024 · CA
Combinatorial application of nanoscale technologies to target a novel mechanism of immune evasion by cancer cells
$690,825Shiladitya Sengupta · Brigham And Women'S Hospital · R01 · FY2025 · CA